Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle
Naunyn-Schmiedeberg s Archives of Pharmacology1981Vol. 318(2), pp. 130–134
Related Papers
- → Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders(1991)125 cited
- → New Developments on Thromboxane and Prostacyclin Modulators Part I: Thromboxane Modulators(2004)76 cited
- → Thromboxane Modulating Agents. 3. 1H-Imidazol-1-ylalkyl- and 3-Pyridinylalkyl-Substituted 3-[2-[(Arylsulfonyl)amino]ethyl]benzenepropanoic Acid Derivatives as Dual Thromboxane Synthase Inhibitor/Thromboxane Receptor Antagonists(1997)15 cited
- → Antihypertensive effect of thromboxane A2 receptor blockade in genetically hypertensive rats of the Lyon strain(1989)14 cited
- Thromboxane A2/prostaglandin H2 receptor antagonists. A new therapeutic principle.(1990)